Omvoh Delivers 4-Year Disease Clearance in Ulcerat...
Category : Clinical Trial Update 6 May 2026Long-term remission in ulcerative colitis (UC) has always been the goal. Durable disease clearance?...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
GRIN Therapeutics Expands Phase 3 Trial of Radipro...
Category : Clinical Trial Update 6 May 2026Rare neurodevelopmental disorders are often underserved—and even more rarely targeted at the r...
FDA Expands Asceniv Label to Include Pediatric Pat...
Category : Approval/Launch 6 May 2026For companies operating in niche biologics, label expansion is often more valuable than new approval...
Ascidian Advances RNA Editing Therapy ACDN-01 into...
Category : Clinical Trial Update 6 May 2026In genetic medicine, most approaches try to replace or edit DNA. Ascidian Therapeutics is taking a d...
Neurocrine Bets on CRF Biology for Obesity: First-...
Category : Clinical Trial Update 5 May 2026The obesity drug race just got a new contender—and it’s not another GLP-1 copycat. Ne...
Latest Newsletter Post
-
Ascidian Advances RNA Editing Thera..
6 May 2026
-
FDA Expands Asceniv Label to Includ..
6 May 2026
-
GRIN Therapeutics Expands Phase 3 T..
6 May 2026
-
Omvoh Delivers 4-Year Disease Clear..
6 May 2026
-
UCB Drops $2B on Candid Therapeutic..
5 May 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com